ZTOX

Suven Life Sciences (SUVEN): General Updates

General Updates Suven Life Sciences Limited has informed the Exchange rectification order for assesment year 2020-21 Suven Life Sciences Limited has informed the Exchange rectification order for assesment year 2020-21

Suven Life Sciences (SUVEN): General Updates

Suven Life Sciences (SUVEN): Company Update

Company Update Rectification order for Assesment year 2020-21 Rectification order for Assesment year 2020-21

Suven Life Sciences (SUVEN): Company Update

Company Update Rectification order for Assesment year 2020-21 Rectification order for Assesment year 2020-21

Suven Life Sciences (SUVEN) Sees Unusual Trading Activity – What It Means

Suven Life Sciences (SUVEN) recorded unusual trading activity on Chartink scans, with 2.41M shares changing hands. The stock fell 2.27% to ₹269.10 on high volume.

Market Updates Chartink scans

Suven Life Sciences (SUVEN): 🚀 Volume Explosion: SUVEN Breaks 60-Day Average!

💹 Change: ▼ -2.34% 💰 Price: ₹268.90 📊 Volume: 2.41M 🔍 What's happening? Unusual trading activity detected! This could signal a potential breakout or significant news impact. 💡 Pro Tip: Always conduct thorough research before making investment decisions.

SUVEN Stock Falls 2% as Unusual Volume Triggers ZTOX Alert

Suven Life Sciences (SUVEN) fell 2.02% to ₹269.80 as ZTOX detected unusual volume of 2.36 million shares, signaling potential technical breakout activity.

Market Updates Chartink scans

SUVEN Stock at ₹273.40 with Unusual Volume Activity — ZTOX Daily Scan

Suven Life Sciences (SUVEN) stock fell 0.71% to ₹273.40 with 2.22 million shares traded, signaling unusual trading activity on Tuesday.

Market Updates NSE filings

Suven Life Sciences DSMB Review: Phase 3 Masupirdine Study Advances

Suven Life Sciences (NSE: SUVEN) announced positive findings from a DSMB safety review and interim analysis of its ongoing global Phase 3 study of Masupirdine for Alzheimer's Disease Agitation.